These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 21810932)
61. Hepatic COX-2 expression protects mice from an alcohol-high fat diet-induced metabolic disorder by involving protein acetylation related energy metabolism. Chen M; Sun X; Wei W; Cucarella C; Martín-Sanz P; Casado M; Pi L; Ren B; Cao Q Alcohol; 2021 May; 92():41-52. PubMed ID: 33662521 [TBL] [Abstract][Full Text] [Related]
62. Transgenic Overexpression of HDAC9 Promotes Adipocyte Hypertrophy, Insulin Resistance and Hepatic Steatosis in Aging Mice. Veerapaneni P; Goo B; Ahmadieh S; Shi H; Kim DS; Ogbi M; Cave S; Chouhaita R; Cyriac N; Fulton DJ; Verin AD; Chen W; Lei Y; Lu XY; Kim HW; Weintraub NL Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672510 [TBL] [Abstract][Full Text] [Related]
63. ENPP1 variants and haplotypes predispose to early onset obesity and impaired glucose and insulin metabolism in German obese children. Böttcher Y; Körner A; Reinehr T; Enigk B; Kiess W; Stumvoll M; Kovacs P J Clin Endocrinol Metab; 2006 Dec; 91(12):4948-52. PubMed ID: 16968801 [TBL] [Abstract][Full Text] [Related]
64. ROCK1 isoform-specific deletion reveals a role for diet-induced insulin resistance. Lee SH; Huang H; Choi K; Lee DH; Shi J; Liu T; Chun KH; Seo JA; Lima IS; Zabolotny JM; Wei L; Kim YB Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E332-43. PubMed ID: 24326423 [TBL] [Abstract][Full Text] [Related]
65. Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation. Hoy AJ; Bruce CR; Turpin SM; Morris AJ; Febbraio MA; Watt MJ Endocrinology; 2011 Jan; 152(1):48-58. PubMed ID: 21106876 [TBL] [Abstract][Full Text] [Related]
66. Transcriptional activation of ENPP1 by osterix in osteoblasts and osteocytes. Gao MM; Su QN; Liang TZ; Ma JX; Liang TZ; Stoddart MJ; Richards RG; Zhou ZY; Zou NX Eur Cell Mater; 2018 Jul; 36():1-14. PubMed ID: 30047979 [TBL] [Abstract][Full Text] [Related]
67. Resveratrol ameliorates metabolic disorders and insulin resistance in high-fat diet-fed mice. Gong L; Guo S; Zou Z Life Sci; 2020 Feb; 242():117212. PubMed ID: 31884092 [TBL] [Abstract][Full Text] [Related]
68. Dietary effects on body composition, glucose metabolism, and longevity are modulated by skeletal muscle mitochondrial uncoupling in mice. Keipert S; Voigt A; Klaus S Aging Cell; 2011 Feb; 10(1):122-36. PubMed ID: 21070590 [TBL] [Abstract][Full Text] [Related]
69. Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation. Nam HK; Liu J; Li Y; Kragor A; Hatch NE J Biol Chem; 2011 Nov; 286(45):39059-71. PubMed ID: 21930712 [TBL] [Abstract][Full Text] [Related]
70. Editorial: The pleiotropic effect of the ENPP1 (PC-1) gene on insulin resistance, obesity, and type 2 diabetes. Prudente S; Trischitta V J Clin Endocrinol Metab; 2006 Dec; 91(12):4767-8. PubMed ID: 17148571 [No Abstract] [Full Text] [Related]
71. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance. Nuotio-Antar AM; Poungvarin N; Li M; Schupp M; Mohammad M; Gerard S; Zou F; Chan L Endocrinology; 2015 Nov; 156(11):4020-32. PubMed ID: 26248218 [TBL] [Abstract][Full Text] [Related]
72. Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance. Dong H; Maddux BA; Altomonte J; Meseck M; Accili D; Terkeltaub R; Johnson K; Youngren JF; Goldfine ID Diabetes; 2005 Feb; 54(2):367-72. PubMed ID: 15677494 [TBL] [Abstract][Full Text] [Related]
73. Role of somatomedin-B-like domains on ENPP1 inhibition of insulin signaling. Dimatteo C; Marucci A; Palazzo A; Cisternino C; Marsano RM; Trischitta V; Di Paola R Biochim Biophys Acta; 2013 Mar; 1833(3):552-8. PubMed ID: 23098853 [TBL] [Abstract][Full Text] [Related]
74. The diabetes gene Zfp69 modulates hepatic insulin sensitivity in mice. Chung B; Stadion M; Schulz N; Jain D; Scherneck S; Joost HG; Schürmann A Diabetologia; 2015 Oct; 58(10):2403-13. PubMed ID: 26232096 [TBL] [Abstract][Full Text] [Related]
75. Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance. Liu M; Xiang R; Wilk SA; Zhang N; Sloane LB; Azarnoush K; Zhou L; Chen H; Xiang G; Walter CA; Austad SN; Musi N; DeFronzo RA; Asmis R; Scherer PE; Dong LQ; Liu F Diabetes; 2012 Nov; 61(11):2776-86. PubMed ID: 22807031 [TBL] [Abstract][Full Text] [Related]
76. Delayed intervention with a novel SGLT2 inhibitor NGI001 suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice. Chiang H; Lee JC; Huang HC; Huang H; Liu HK; Huang C Br J Pharmacol; 2020 Jan; 177(2):239-253. PubMed ID: 31497874 [TBL] [Abstract][Full Text] [Related]
77. Overexpressing high levels of human vaspin limits high fat diet-induced obesity and enhances energy expenditure in a transgenic mouse. Rapöhn I; Elias I; Weiner J; Pujol A; Kehr S; Chadt A; Al-Hasani H; Burkhardt R; Klöting N; Stumvoll M; Bosch F; Kovacs P; Heiker JT; Breitfeld J Front Endocrinol (Lausanne); 2023; 14():1146454. PubMed ID: 37152954 [TBL] [Abstract][Full Text] [Related]
78. The hepatic ectonucleotide pyrophosphatase/phosphodiesterase 1 gene mRNA abundance is reduced by insulin and induced by dexamethasone. Ma H; Wang P; Jin D; Jia T; Mao H; Zhang J; Zhao S Braz J Med Biol Res; 2018 Mar; 51(4):e6980. PubMed ID: 29513794 [TBL] [Abstract][Full Text] [Related]
79. Fatty liver and insulin resistance: not always linked. Schonfeld G; Yue P; Lin X; Chen Z Trans Am Clin Climatol Assoc; 2008; 119():217-23; discussion 223-4. PubMed ID: 18596860 [TBL] [Abstract][Full Text] [Related]